HF
FLGT icon

HRT Financial’s Fulgent Genetics FLGT Stock Holding History

HRT Financial’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.71M Buy
229,444
+182,996
+394% +$3.1M 0.01% 1180
2026
Q1 		$738K Sell
46,448
-77,775
-63% -$1.69M ﹤0.01% 2246
2025
Q4 		$3.26M Buy
124,223
+17,939
+17% +$465K 0.01% 995
2025
Q3 		$2.4M Buy
106,284
+6,796
+7% +$140K 0.01% 1046
2025
Q2 		$1.98M Sell
99,488
-72,188
-42% -$1.41M 0.01% 933
2025
Q1 		$2.9M Buy
171,676
+129,469
+307% +$2.21M 0.02% 656
2024
Q4 		$779K Buy
42,207
+13,789
+49% +$269K ﹤0.01% 1211
2024
Q3 		$617K Buy
+28,418
New +$635K ﹤0.01% 1488
2023
Q3 		– Sell
-5,630
Closed -$208K – 2620
2023
Q2 		$208K Sell
5,630
-29,807
-84% -$1.04M ﹤0.01% 1823
2023
Q1 		$1.11M Buy
35,437
+6,867
+24% +$221K 0.01% 896
2022
Q4 		$850K Buy
+28,570
New +$1.02M 0.01% 1060

Other funds holding FLGT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

HRT Financial's FLGT Position: Q2 2026 in Review

HRT Financial increased its Fulgent Genetics (FLGT) stake by 394% in Q2 2026, buying an estimated $3.1M and bringing the position to 229,444 shares worth $4.71M. The position accounts for 0.01% of the portfolio, ranked #1180.

HRT Financial first reported a position in FLGT in Q4 2022 and has held it in 11 quarters since. 142 funds tracked by Wall St. Rank hold FLGT as of Q2 2026.

  • HRT Financial held 229,444 shares of Fulgent Genetics worth $4.71M as of Q2 2026.
  • HRT Financial bought 182,996 Fulgent Genetics shares in Q2 2026, an estimated $3.1M.
  • Fulgent Genetics made up 0.01% of HRT Financial's portfolio in Q2 2026, its #1180 holding.
  • HRT Financial first reported a position in Fulgent Genetics in Q4 2022 and has held it in 11 quarters since.
  • 142 funds tracked by Wall St. Rank held Fulgent Genetics as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.